Autopsy report · NCT00674141

Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment

“was not approved by the ministry of health”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Hadassah Medical Organization

Sponsor type

University, hospital or other

Conditions

MS Patient With Relpasing Remitting Attacks

Interventions

Dexamethasone soduim phosphate

Participants

10 (planned, not actual)

Sites

1

Countries

Israel

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.